pouchitis

August 5, 2019August 5, 2019

Camligo Trial Yields Mixed Results in Patients with Pouchitis

News

Atlantic Healthcare’s Camligo (alicaforsen enema) did not meet the primary endpoints of the Phase 3 clinical trial that aimed to evaluate the efficacy of the drug in patients with pouchitis. ... Read more

May 9, 2018May 9, 2018

Atlantic Healthcare Completes Phase 3 Trial Enrollment for Alicaforsen as Pouchitis Treatment

News

Atlantic Healthcare has completed enrollment for a Phase 3 trial evaluating the safety and efficacy of alicaforsen in patients with pouchitis, a frequent complication after surgery to treat different forms ... Read more

November 15, 2016November 15, 2016

US Patent Issued for Atlantic Healthcare’s Alicaforsen to Treat IBD Pouchitis

News

A U.S. patent has been issued to Atlantic Healthcare’s investigational drug alicaforsen for the treatment of inflammatory bowel disease (IBD). The patent (No. 9453221) extends the use of alicaforsen in IBD-related rectal stump inflammation and ... Read more

February 23, 2016February 23, 2016

Topical Treatment for Inflammatory Bowel Disease Pouchitis Starts Pivotal Phase 3 Trial, Now Enrolling Patients

News

Atlantic Healthcare plc announced that it is now enrolling patients in a Phase 3 clinical trial to assess alicaforsen enema for the treatment of inflammatory bowel disease (IBD) pouchitis. Pouchitis, the inflammation of ... Read more